These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5338679)

  • 21. Effects of LSD-25 and dextroamphetamine on speech rhythms in psychotherapy dialogues.
    Jaffe J; Dahlberg CC; Luria J; Chorosh J
    Biol Psychiatry; 1973 Feb; 6(1):93-6. PubMed ID: 4710779
    [No Abstract]   [Full Text] [Related]  

  • 22. LSD enhances suggestibility in healthy volunteers.
    Carhart-Harris RL; Kaelen M; Whalley MG; Bolstridge M; Feilding A; Nutt DJ
    Psychopharmacology (Berl); 2015 Feb; 232(4):785-94. PubMed ID: 25242255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Authenticity and sole of regressive experiences during analytical LSD psychotherapy].
    Havlícek Z
    Cesk Psychiatr; 1968 Aug; 64(4):236-40. PubMed ID: 5680671
    [No Abstract]   [Full Text] [Related]  

  • 24. Creativity: hot and cold.
    Taft R
    J Pers; 1971 Sep; 39(3):345-61. PubMed ID: 4939787
    [No Abstract]   [Full Text] [Related]  

  • 25. Cognitive test performance under LSD-25, placebo and isolation.
    Goldberger L
    J Nerv Ment Dis; 1966 Jan; 142(1):4-9. PubMed ID: 5326508
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemical agents for behavior change: "creative, psychotic and ecstatic states"--some implications for drug education.
    McWhinnie HJ
    Br J Addict Alcohol Other Drugs; 1970 Aug; 65(2):123-37. PubMed ID: 5274149
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical prediction of insightful response to a single large dose of LSD.
    Eggert DC; Shagass C
    Psychopharmacologia; 1966; 9(4):340-6. PubMed ID: 4871474
    [No Abstract]   [Full Text] [Related]  

  • 28. Age and effect of LSD-25 on pupil size and kneejerk threshold. Studies in chronic schizophrenic and nonpsychotic subjects.
    Wikler A; Rosenberg DE; Hawthorne JD; Cassidy TM
    Psychopharmacologia; 1965 Jan; 7(1):44-56. PubMed ID: 5318923
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterizing the psychological state produced by LSD.
    Katz MM; Waskow IE; Olsson J
    J Abnorm Psychol; 1968 Feb; 73(1):1-14. PubMed ID: 5639999
    [No Abstract]   [Full Text] [Related]  

  • 30. Mental age regression induced by lysergic acid diethylamide.
    Lienert G
    J Psychol; 1966 May; 63(1):3-11. PubMed ID: 5944667
    [No Abstract]   [Full Text] [Related]  

  • 31. Some clinical and social aspects of lysergic acid diethylamidel. II.
    Sarwer-Foner GJ
    Psychosomatics; 1972; 13(5):309-16. PubMed ID: 4605126
    [No Abstract]   [Full Text] [Related]  

  • 32. An evaluation of aversion and LSD therapy in the treatment of alcoholism.
    Costello CG
    Can Psychiatr Assoc J; 1969 Feb; 14(1):31-42. PubMed ID: 4888140
    [No Abstract]   [Full Text] [Related]  

  • 33. A psychopharmacological test of the body image hypothesis.
    SILVERSTEIN AB; KLEE GD
    J Nerv Ment Dis; 1958 Oct; 127(4):323-9. PubMed ID: 13599038
    [No Abstract]   [Full Text] [Related]  

  • 34. Tolerance development to central injection of LSD.
    Carino MA; Chesnut RM; Weick BG; Horita A
    Proc West Pharmacol Soc; 1975; 18():369-70. PubMed ID: 1178697
    [No Abstract]   [Full Text] [Related]  

  • 35. Reaction time ("mental set") in control and chronic schizophrenic subjects and in postaddicts under placebo, LSD-25, morphine, pentobarbital and amphetamine.
    Wikler A; Haertzen CA; Chessick RD; Hill HE; Pescor FT
    Psychopharmacologia; 1965 May; 7(6):423-43. PubMed ID: 5319301
    [No Abstract]   [Full Text] [Related]  

  • 36. LSD modulates music-induced imagery via changes in parahippocampal connectivity.
    Kaelen M; Roseman L; Kahan J; Santos-Ribeiro A; Orban C; Lorenz R; Barrett FS; Bolstridge M; Williams T; Williams L; Wall MB; Feilding A; Muthukumaraswamy S; Nutt DJ; Carhart-Harris R
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1099-109. PubMed ID: 27084302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute and chronic LSD effects on rat startle: data supporting an LSD--rat model of schizophrenia.
    Braff DL; Geyer MA
    Biol Psychiatry; 1980 Dec; 15(6):909-16. PubMed ID: 7193055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic trial of lysergic Acid diethylamide (LSD) and thioridazine in chronic schizophrenia.
    Shirvaikar RV; Kelkar YW
    Neurol India; 1966; 14(2):97-101. PubMed ID: 5330728
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.